Orville
Back to product list
Elcar 1Elcar 2Elcar 3Elcar 4Elcar 5Elcar 6

Elcar

Composition: Active ingredient: levocarnitine 300 mg. Excipients: citric acid monohydrate 1.2 mg, methyl parahydroxybenzoate 0.5 mg, propyl parahydroxybenzoate 0.2 mg, purified water up to 1 ml.

Form: Oral solution

Indications: Intensive physical and emotional stress, rehabilitation after illnesses and surgeries, chronic gastritis and pancreatitis with reduced secretion, skin diseases (psoriasis, eczema, etc.), mild hyperthyroidism, vascular and traumatic brain injuries, anorexia, carnitine deficiency, growth retardation in children, sports medicine.

Contraindications: Individual intolerance.

Dosage: Taken orally 30 minutes before meals diluted in water. Adults: 0.75 g to 2.5 g depending on indication. Children from 3 years: dosage adjusted individually. Course duration: 1 to 8 weeks.

Side effects: Rare: allergic reactions, gastric pain, dyspepsia, myasthenia (in patients with uremia).

Interactions: Glucocorticoids enhance levocarnitine accumulation. Anabolic agents increase the effect.

Warnings: In diabetic patients, adjustment of hypoglycemic medication may be required. Use in children under 3 only under medical supervision.

Age restrictions: From birth (under pediatrician supervision)

Pregnancy: Permitted during pregnancy and breastfeeding if the benefits outweigh the potential risks.

Manufacturer: PIK-PHARMA

Storage conditions: Store below 25 °C, out of reach of children.

Clinical studies:

The role of L-carnitine in treating postnatal hypotrophy in premature infants after discharge from neonatal care

Clinical Practice in Pediatrics, 2017

Authors: M.Ya. Ledyaev, T.E. Zayachnikova

Read

Posthypoxic cardiomyopathy in newborns: new treatment opportunities

PEDIATRICS, 2017

Authors: S.V. Garina, L.A. Balykova, I.S. Nazarova, N.R. Belkina, E.S. Glukhova

Read

Treatment of newborns and young children with prolonged conjugated hyperbilirubinemia

PEDIATRICS, 2012

Authors: S.V. Garina, L.A. Balykova, I.S. Nazarova, N.R. Belkina, E.S. Glukhova

Read

Modern approaches to treating frequently ill children

Pediatric Practice, 2016

Authors: O.V. Goncharova, G.V. Kuranov

Read

On the advisability of using carnitine drugs for treating vegetative dystonia syndrome in children

Pediatric Practice, 2017

Authors: E.V. Neudakhin, O.E. Talitskaya

Read

Carnitine deficiency in children: causes, prevention, and treatment

Russian Bulletin of Perinatology and Pediatrics, 2008

Authors: E.A. Nikolaeva, M.Ya. Ledyaev, S.O. Klyuchnikov

Read

Early diagnosis of carnitine deficiency in premature newborns

Russian Bulletin of Perinatology and Pediatrics, 2018

Authors: U.F. Nasirova, R.M. Tastanova, A.A. Pak, M.K. Sharipova

Read

Elcar in pediatric practice

Pharmacology, 2007

Authors: U.F. Nasirova, R.M. Tastanova, A.A. Pak, M.K. Sharipova

Read

Results and prospects of using energy-targeted therapy in pediatrics: the example of L-carnitine

Issues in Practical Pediatrics, 2009

Authors: L.A. Balykova

Read

From science to practice: a journey of a hundred years

Medical Newspaper, 2006

Authors: Irina Andreeva

Read

Correction of autonomic homeostasis and intracellular energy metabolism disorders in frequently ill children

RSMU, 2007

Authors: T.N. Nakostenko, S.O. Klyuchnikov, V.S. Sukhorukov

Read

Where to buy: